Stay updated on DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.

Latest updates to the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNo significant additions or deletions were detected in the Study Details page; core information such as the study title, conditions, interventions, eligibility criteria, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a government funding status notice and updated the version to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference3%

- Check47 days agoChange DetectedRemoved several drug-safety and pharmaceutical quality topics and updated version to v3.1.0. Core content areas and safety-related topics were reduced.SummaryDifference0.8%

- Check61 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2; removed the 'Back to Top' link. No other substantive changes (pricing, stock, or time-slot information).SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific drug information related to Lanadelumab and the inclusion of new facility and location details, while removing previous location references.SummaryDifference3%

Stay in the know with updates to DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.